Caunca, Michelle R.
Wang, Lily
Cheung, Ying Kuen
Alperin, Noam
Lee, Sang H.
Elkind, Mitchell S. V.
Sacco, Ralph L.
Wright, Clinton B.
Rundek, Tatjana
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01 NS29993)
National Institute of Neurological Disorders and Stroke (F30 NS103462)
Evelyn F. McKnight Brain Research Foundation
Article History
First Online: 1 August 2020
Compliance with ethical standards
: Participants provided written informed consent, and the institutional review boards at the University of Miami and Columbia University approved this study.
: Dr. Mitchell S.V. Elkind receives compensation for providing consultative services for the BMS-Pfizer Alliance for Eliquis, and Roche for a clinical trial of stroke prevention; has given expert legal opinions on behalf of Organon (NuvaRing and stroke litigation), Auxilium (testosterone and stroke), and LivaNova (cardiac surgery and stroke); and serves on the National, Founders Affiliate, and New York City Chapter Boards of the American Heart Association/American Stroke Association. He receives royalties from UpToDate for chapters related to stroke.Dr. Ralph L. Sacco receives federal grant support (R01 NS 29993, CTSA UL1 TR002736), private foundation support (American Heart Association Bugher Center), and pharma research support (Boehringer Ingelheim).Dr. Clinton B. Wright receives royalties for 2 chapters on Vascular Dementia from UpToDate.Drs. Michelle Caunca, Lily Wang, Ying Kuen Cheung, Noam Alperin, and Tatjana Rundek and Mr. Sang Lee report no disclosures.